Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder

Phase: PHASE2 | Sponsor: University of California, Los Angeles | Compound: Psilocybin

Status

planned

Institution

University of California, Los Angeles

Start date

2027-01-01

End date

2028-12-01

Registry ID

NCT07566104

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.